• Ziprasidone Hydrochloride (A5350): Mechanistic Benchmarks...

  2026-03-04

  Ziprasidone Hydrochloride (Ziprasidone HCl) is a rigorously characterized second-generation antipsychotic with dual action as a serotonin/dopamine receptor antagonist and a GOT1 inhibitor. Validated in both neuroscience and cancer cell models, it offers reproducible pharmacodynamic benchmarks for translational studies. APExBIO provides high-purity Ziprasidone HCl to support advanced research across receptor signaling, glutamine metabolism, and tumor biology.

• Ziprasidone Hydrochloride: Advanced Mechanisms and Transl...

  2026-03-04

  Explore the multifaceted mechanisms of Ziprasidone Hydrochloride, a leading serotonin and dopamine receptor antagonist, in both neuroscience and cancer research. This comprehensive article uncovers novel insights into GOT1 inhibition and translational oncology models, offering depth beyond standard antipsychotic research.

• Scenario-Driven Optimization with Ziprasidone Hydrochlori...

  2026-03-03

  This article equips biomedical researchers and technical staff with scenario-based guidance on addressing key challenges in cell viability, cytotoxicity, and oncology assays using Ziprasidone Hydrochloride (SKU A5350). Drawing on quantitative data, recent literature, and APExBIO’s validated formulation, the article demonstrates how A5350 enhances reproducibility, sensitivity, and workflow safety in both in vitro and translational research settings.

• Ziprasidone Hydrochloride: Integrating Dopaminergic and M...

  2026-03-03

  Discover the multifaceted roles of Ziprasidone Hydrochloride as a serotonin and dopamine receptor antagonist and GOT1 inhibitor. This comprehensive review explores its dual impact on neuropsychiatric and oncology models, with new insights into impurity profiling and translational research applications.

• Ziprasidone Hydrochloride: Mechanism, Evidence & Research...

  2026-03-02

  Ziprasidone Hydrochloride (Ziprasidone HCl) is a second-generation antipsychotic with validated antagonism at dopamine and serotonin receptors, and direct inhibition of GOT1, enabling dual applications in neuroscience and cancer research. It demonstrates robust, quantifiable antiproliferative and apoptosis-inducing effects in vitro, alongside favorable safety and permeability profiles. This article details atomic facts, key study benchmarks, and actionable parameters, extending the evidence base for translational research.

• Ziprasidone Hydrochloride: Advanced Mechanisms and Nanocr...

  2026-03-02

  Explore the multifaceted science of Ziprasidone Hydrochloride, a serotonin and dopamine receptor antagonist with unique antitumor capabilities. This article delves into its advanced molecular mechanisms, nanocrystal bioavailability breakthroughs, and emerging applications in both neuroscience and oncology.

• Ziprasidone Hydrochloride (A5350): Atomic Benchmarks for ...

  2026-03-01

  Ziprasidone Hydrochloride (Ziprasidone HCl) is a second-generation antipsychotic and validated serotonin/dopamine receptor antagonist with additional GOT1 inhibitory, antiproliferative, and apoptosis-inducing activities. This article compiles atomic, machine-readable facts and quantitative benchmarks to support neuroscience and cancer research, establishing APExBIO's A5350 as a rigorously characterized research reagent.

• Ziprasidone Hydrochloride: Mechanisms, GOT1 Inhibition, a...

  2026-02-28

  Ziprasidone Hydrochloride (Ziprasidone HCl) is a second-generation antipsychotic and GOT1 inhibitor with dual roles in neuroscience and cancer research. Evidence supports its function as a high-affinity serotonin and dopamine receptor antagonist and a non-competitive inhibitor of glutamic-oxaloacetic transaminase 1, disrupting tumor metabolism. This article details verifiable facts, experimental conditions, and integration recommendations for translational research.

• Ziprasidone HCl: Translational Workflows for Neuroscience...

  2026-02-27

  Ziprasidone HCl uniquely bridges dopaminergic and serotonergic pathway research with innovative cancer metabolism studies, enabling robust experimental workflows. APExBIO’s high-purity formulation empowers researchers to achieve reliable, reproducible results in both psychotic disorder models and tumor cell assays.

• Ziprasidone Hydrochloride (SKU A5350): Reliable Solutions...

  2026-02-27

  This expert-driven guide addresses persistent laboratory challenges in cell viability, cytotoxicity, and cancer metabolism assays, demonstrating how Ziprasidone Hydrochloride (SKU A5350) from APExBIO offers reproducible, data-backed solutions. Scenario-based Q&A blocks integrate quantitative benchmarks and validated best practices, supporting biomedical researchers seeking consistent, high-impact results with Ziprasidone HCl.

• Ziprasidone Hydrochloride in Translational Research: Dual...

  2026-02-26

  This thought-leadership article dissects the multifaceted mechanisms and translational opportunities of Ziprasidone Hydrochloride (Ziprasidone HCl, SKU: A5350), a second-generation antipsychotic that doubles as a GOT1 inhibitor for advanced cancer research. We explore the compound’s impact on dopaminergic and serotonergic signaling, its emerging role in tumor metabolism modulation, and strategic guidance for researchers pursuing cross-disciplinary breakthroughs. Drawing on recent impurity profiling and mechanistic advances—anchored by APExBIO’s rigorously characterized formulation—we chart a visionary path for maximizing impact in both neuroscience and oncology.

• Ziprasidone Hydrochloride: Dual Mechanistic Leverage for ...

  2026-02-26

  Discover how Ziprasidone Hydrochloride (Ziprasidone HCl, SKU A5350) redefines experimental possibilities for translational researchers at the intersection of neuropharmacology and cancer metabolism. This in-depth thought-leadership article unpacks the compound’s multifaceted mechanisms—spanning serotonin and dopamine receptor antagonism to non-competitive GOT1 inhibition—while delivering actionable insights for optimizing workflows, advancing mechanistic understanding, and accelerating bench-to-bedside translation. Integrating cutting-edge formulation science and robust experimental evidence, we chart a strategic roadmap for leveraging APExBIO’s validated Ziprasidone Hydrochloride in both fundamental discovery and applied research.

• Ziprasidone Hydrochloride: Mechanistic Insights and Next-...

  2026-02-25

  Explore the advanced mechanism of Ziprasidone Hydrochloride, a serotonin and dopamine receptor antagonist and GOT1 inhibitor, in neuroscience and cancer research. This article uniquely dissects redox disruption and translational strategies, offering deeper scientific and experimental perspectives.

• Ziprasidone Hydrochloride: Novel GOT1 Inhibition for Next...

  2026-02-25

  Explore how Ziprasidone Hydrochloride, a potent serotonin and dopamine receptor antagonist, is redefining cancer metabolism research as a GOT1 inhibitor. This article provides a mechanistic deep dive and strategic guidance for advanced oncology and neuroscience workflows.

• Ziprasidone Hydrochloride (Ziprasidone HCl): A Dual-Mecha...

  2026-02-24

  This thought-leadership article explores the dual mechanistic profile of Ziprasidone Hydrochloride (Ziprasidone HCl, SKU A5350), highlighting its value for translational researchers in both neuroscience and cancer metabolism. Moving beyond standard product pages, it integrates new insights into glutamine metabolism reprogramming and tumor redox disruption, while providing actionable strategies for experimental design, impurity profiling, and clinical translation. Evidence from peer-reviewed studies and cutting-edge research is woven throughout, with strategic guidance on maximizing data robustness and translational relevance.

407 records 23/28 page Previous Next First page 上5页 2122232425 下5页 Last page